Widespread displacement of DNA- and RNA-binding factors underlies toxicity of arginine-rich cell-penetrating peptides.

Lafarga, VanesaSirozh, OleksandraDíaz-López, IreneGalarreta, AntonioHisaoka, MisaruZarzuela, EduardoBoskovic, JasminkaJovanovic, BogdanFernandez-Leiro, RafaelMuñoz, JaimeStoecklin, GeorgVentoso, IvánFernandez-Capetillo, OscarSirozh, OleksandraDíaz-López, IreneGalarreta, AntonioHisaoka, MisaruZarzuela, EduardoJovanovic, BogdanFernandez-Leiro, RafaelMuñoz, JaimeStoecklin, GeorgVentoso, Iván2024-10-112024-10-112021-07-01https://hdl.handle.net/20.500.12105/25089Due to their capability to transport chemicals or proteins into target cells, cell-penetrating peptides (CPPs) are being developed as therapy delivery tools. However, and despite their interesting properties, arginine-rich CPPs often show toxicity for reasons that remain poorly understood. Using a (PR)n dipeptide repeat that has been linked to amyotrophic lateral sclerosis (ALS) as a model of an arginine-rich CPP, we here show that the presence of (PR)n leads to a generalized displacement of RNA- and DNA-binding proteins from chromatin and mRNA. Accordingly, any reaction involving nucleic acids, such as RNA transcription, translation, splicing and degradation, or DNA replication and repair, is impaired by the presence of the CPPs. Interestingly, the effects of (PR)n are fully mimicked by protamine, a small arginine-rich protein that displaces histones from chromatin during spermatogenesis. We propose that widespread coating of nucleic acids and consequent displacement of RNA- and DNA-binding factors from chromatin and mRNA accounts for the toxicity of arginine-rich CPPs, including those that have been recently associated with the onset of ALS.We would want to thank Drs. Andre Nussenzweig an Jordi Carreras-Puigvert for insightful comments on the manuscript. Research was funded by Fundacion Botin, by Banco Santander through its Santander Universities Global Division and by grants from the Spanish Ministry of Science, Innovation and Universities (RTI2018-102204-B-I00, co-financed with European FEDER funds) and the European Research Council (ERC-617840) to OF; DKFZ NCT3.0 Integrative Project in Cancer Research grant (NCT3.0_2015.54 DysregPT) and SFB 1036/TP07 from the Deutsche Forschungsgemeinschaft to G.S.enghttp://creativecommons.org/licenses/by/4.0/ALSarginine-rich peptideschromatinmRNAprotamineWidespread displacement of DNA- and RNA-binding factors underlies toxicity of arginine-rich cell-penetrating peptides.research articleAttribution 4.0 International33978236open access